Post by mary on May 6, 2020 1:02:03 GMT
The mutation has been pinned down, and the second worse strain is referred to as G. There will be stories coming out. It appears Italy has had much more of this second strain.
Also, guess why some of NIH people prefer Gilead's Remdesivir to Hydroxychloroquine and Azithromyacin:
The Pseudo-Science Behind The Mysterious Assault On Hydroxychloroquine
HCQ-based treatments are effective in treating COVID-19, unless started too late.
Studies, cited in opposition, have been misinterpreted, invalid, or worse.
HCQ and AZ are some of the most tested and safest prescription drugs.
The COVID-19 Treatment Panel of NIH evaded disclosure of the massive financial links of its members to Gilead Sciences, the manufacturer of a competing drug remdesivir. Among those who failed to disclose such links are 2 out of 3 of its co-chairs.
HCQ-based treatments are effective in treating COVID-19, unless started too late.
Studies, cited in opposition, have been misinterpreted, invalid, or worse.
HCQ and AZ are some of the most tested and safest prescription drugs.
The COVID-19 Treatment Panel of NIH evaded disclosure of the massive financial links of its members to Gilead Sciences, the manufacturer of a competing drug remdesivir. Among those who failed to disclose such links are 2 out of 3 of its co-chairs.
That was part of an item by Tyler Durden on ZeroHedge
